Alexis Brice – Director, Brain & Spine Institute (ICM), France
Prof. Alexis Brice, director of the French Brain & Spine Institute (Institut du Cerveau et de la Moelle épinière (ICM)), reveals the recipe behind the success of the center since…
Address: 26 Kallang Place #05-17 Singapore 339157,Singapore
Tel: + (65) 6299 5411
Web: http://www.icmpharma.com.sg/
ICM started in Singapore as a trading entity in 1970 under the name of Woods International Pte Ltd, which now becomes the marketing arm of veterinary products in Singapore and Malaysia. It is also their official tendering agency for pharmaceutical products to the public sector in Singapore.
There manufacturing activities started in 1975 for the range of veterinary products under Carrington brand. In the 1980s, they obtained Good Manufacturing Practice (GMP) certification from Ministry of Health (Singapore) for production of human pharmaceuticals. Thier facilities are capable of producing oral preparations, external preparations, creams and ointments.
ICM is now one of the largest local pharmaceutical manufacturers in Singapore. They have expanded into an organisation with over 60 staffs, headed by a group of professionals including pharmacists, quality control and R&D chemists, microbiologist and trained technicians
Their product range includes pharmaceuticals (both ethical and over-the-counter), cosmetics, household products and chemicals for industrial uses. They also do packing of solid dosage forms such as tablets and capsules for their clients.
Prof. Alexis Brice, director of the French Brain & Spine Institute (Institut du Cerveau et de la Moelle épinière (ICM)), reveals the recipe behind the success of the center since…
Victor Manuel Fernández Navarro, CEO at Vicma, explains how strategically important is to have a healthy business model in the distribution industry through sustainable collection period, attractive profit margins and…
Lifetrack Medical Systems’ Dr Eric Schulze explores the origins of his company, how its software platform has the potential to revolutionise radiology workflows in Asia and beyond, and the barriers…
Industry veteran Marine Queniart-Stojanovic, a self-described “global citizen with a French passport,” currently serves as Sanofi’s GM for general medicines in Thailand, Malaysia, and Singapore. With Sanofi undergoing a significant…
Alan Goh of NDR Medical Technology, a pioneer in intelligent navigation and image processing for minimally invasive surgery, introduces the progress of the company to date, how its technology has…
Singapore is one of the healthiest countries in Asia with a life expectancy in excess of 82 years buttressed by one of the most robust healthcare apparatuses in the world.…
IQVIA Biotech JAPAC’s Dr Senthil Sockalingam outlines the evolving needs of the flood of early-stage drug discovery ventures in Asia, how biotechs in the region differ from their counterparts in…
Singapore recently outlined its latest Research, Innovation and Enterprise (RIE) 2025 plan, with plans to invest some USD 20 billion over the next 5 years. Here, three key stakeholders from…
Industry veteran Marine Queniart-Stojanovic outlines the significance of the Thailand-Malaysia-Singapore country grouping to Sanofi’s APAC operations; how the company’s global rationalisation and prioritisation push has been reflected at the country…
Professor Ashok Venkitaraman introduces his work in Singapore, coordinating and catalysing research on the causes of cancer in Asia, and translating this research to clinical impact through improved detection, treatment…
Erika Pagani, country manager for Pfizer Singapore, shares her journey with the company from Brazil to New York, Peru, Ecuador, and finally Singapore. She discusses why the island city-state is…
Beh Kian Teik of Singapore’s National Research Foundation (NRF) outlines the importance of the life sciences within the country’s innovation strategy and the role it has to play at a…
EY’s Abhay Bangi highlights the key trends across the ASEAN life sciences space, how the COVID-19 pandemic has accelerated them, and charts Singapore’s course towards becoming a world-class biotech investment…
Innovation is at the heart of healthcare transformation and the doors for a much-needed shift from provider- to patient-centric solutions have been opened. That is the idea behind HealthBeats™, a…
See our Cookie Privacy Policy Here